Literature DB >> 657713

Oral clonidine loading for rapid control of hypertension.

I M Cohen, M A Katz.   

Abstract

In order to determine the efficacy and safety of oral clonidine loading to control hypertension rapidly, 15 patients received 0.1 or 0.2 mg clonidine initially followed by hourly doses of 0.1 mg until the blood pressure was substantially reduced or until a total of 0.5 mg had been given. Twelve (80%) responded with a reduction in mean blood pressure of 33 +/- 3 (SE) mm Hg in an average time of 2.25 hr. Side effects were minimal. Four of the 5 patients hospitalized solely for purposes of blood pressure control responded to clonidine loading and were discharged the next day. Clonidine loading proved to be safe and effective for rapid control of hypertension and may be preferred to intravenous antihypertensives for some indications.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 657713     DOI: 10.1002/cpt197824111

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

Review 1.  Hypertensive emergencies and urgencies: definition, recognition, and management.

Authors:  J B Reuler; G J Magarian
Journal:  J Gen Intern Med       Date:  1988 Jan-Feb       Impact factor: 5.128

Review 2.  Malignant or accelerated hypertension.

Authors:  N D Vaziri
Journal:  West J Med       Date:  1984-04

Review 3.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

4.  Hypertensive emergencies treated with oral clonidine.

Authors:  G N Karachalios
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Pattern of Blood Pressure Response in Patients With Severe Asymptomatic Hypertension Treated in the Emergency Department.

Authors:  Wasseem Rock; Khaled Zbidat; Naama Schwartz; Mazen Elias; Itamar Minuhin; Reuma Shapira; Ehud Grossman
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-31       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.